amikacin has been researched along with Microbial Superinvasion in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamidou, M; Bacopoulou, F; Markantonis, SL; Pavlou, E | 1 |
| Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 1 |
| Alvarez Lerma, F | 1 |
| Anaissie, EJ; Berkey, P; Bodey, GP; Cabanillas, FF; Elting, L; Holmes, FA; Joshi, JH; Keating, MJ; Khardori, NM; Rolston, KV | 1 |
| Castro, E; McCracken, GH; Odio, CM; Salas, JL; Umaña, MA | 1 |
| Noone, M; Noone, P; Pomeroy, L; Sage, R | 1 |
7 trial(s) available for amikacin and Microbial Superinvasion
| Article | Year |
|---|---|
A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
Topics: Acinetobacter Infections; Adult; Amikacin; Anti-Bacterial Agents; Area Under Curve; Creatinine; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Half-Life; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Prospective Studies; Pseudomonas Infections; Superinfection | 2003 |
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Superinfection | 1995 |
Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Antineoplastic Agents; Ceftazidime; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Mycoses; Prospective Studies; Superinfection | 1996 |
[Efficacy of monotherapy by meropenem in ventilator-associated pneumonia].
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial; Superinfection; Thienamycins | 2001 |
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prognosis; Superinfection | 1992 |
Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections.
Topics: Amikacin; Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Infant, Newborn; Male; Prospective Studies; Randomized Controlled Trials as Topic; Superinfection | 1990 |
Prospective study of amikacin versus netilmicin in the treatment of severe infection in hospitalized patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amikacin; Bacteria; Clinical Trials as Topic; Cross Infection; Ear; Female; Humans; Kidney; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Prospective Studies; Random Allocation; Superinfection | 1989 |